Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001490978-25-000017
Filing Date
2025-03-04
Accepted
2025-03-04 17:26:54
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741127207.html 4  
1 FORM 4 wk-form4_1741127207.xml 4 5974
  Complete submission text file 0001490978-25-000017.txt   7441
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Lorton Kenneth Patrick (Reporting) CIK: 0001797730 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 25706644